BlackRock Fund Advisors - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 63 filers reported holding NIVALIS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$57,000
-71.8%
25,660
+3.1%
0.00%
Q3 2016$202,000
+75.7%
24,880
-0.4%
0.00%
Q2 2016$115,000
-78.9%
24,976
-80.9%
0.00%
Q1 2016$546,000
-48.9%
130,864
-5.2%
0.00%
Q4 2015$1,069,000
-31.3%
138,091
+15.2%
0.00%
Q3 2015$1,555,000119,8590.00%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$48,409,0001.87%
RA Capital Management 612,863$7,949,0001.14%
TIGER MANAGEMENT L.L.C. 650,915$8,442,0001.13%
Opaleye Management Inc. 175,200$2,272,0001.12%
Rock Springs Capital Management LP 489,000$6,342,0000.52%
WALL STREET ASSOCIATES 170,400$2,210,0000.42%
SPHERA FUNDS MANAGEMENT LTD. 201,720$2,616,0000.33%
KINGDON CAPITAL MANAGEMENT, L.L.C. 418,903$5,433,0000.26%
SABBY MANAGEMENT, LLC 384,734$4,990,0000.21%
DAFNA Capital Management LLC 15,000$195,0000.19%
View complete list of NIVALIS THERAPEUTICS INC shareholders